To study the effect of Kushmanda as a food in the management of Amlapitta (Gastritis)

Clinical study on the Effectiveness of modified Khanda Kushmanda as a food supplement in Amlapitta

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/12/022495

Enrollment

Registered

2019-12-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K290- Acute gastritis

Interventions

Intervention1: Khanda Kushmanda as a food supplement in Amlapitta: Shamana chikitsa with Kamaduga tablet 2BD is given before food, along with Khanda kushmanda as a food supplement in a dosage of 12gm

Eligibility

Inclusion criteria

Inclusion criteria: The patients of Amlapitta irrespective of gender and caste. Patients who are willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients who have undergone gastric surgeries. Known cases of gastric & duodenal ulcers. Known cases of gastric malignancies. Known cases of Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Clinical study on the Effectiveness of modified Khanda Kushmanda as a food supplement in AmlapittaTimepoint: assessment will be done on baseline treatment, 7th day, 14th day and 21st day	—

Secondary

Measure	Time frame
to improve the quality of lifeTimepoint: assessment will be done on baseline treatment, 7th day, 14th day and 21st day	—

Countries

India

Contacts

Public ContactDr Vivek M

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

vivekmanohar.1993@gmail.com7829556463

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026